Welcome to our dedicated page for SEAPORT THERAPEUTICS news (Ticker: SPTX), a resource for investors and traders seeking the latest updates and insights on SEAPORT THERAPEUTICS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SEAPORT THERAPEUTICS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SEAPORT THERAPEUTICS's position in the market.
Seaport Therapeutics (Nasdaq: SPTX), a clinical-stage neuropsychiatric therapeutics company, will participate in two investor conferences in June 2026.
The company features in a Goldman Sachs fireside chat on June 10 at 8:00 AM EDT and a UBS Virtual CNS Day fireside chat on June 15 at 10:00 AM EDT. The Goldman Sachs session will be webcast live on Seaport's investor relations site, with an archived replay available. Management will also hold one-on-one investor meetings at both events.
Seaport Therapeutics (Nasdaq: SPTX) priced an upsized initial public offering of 14,160,000 shares at $18.00 per share, generating expected gross proceeds of $254.9 million. The company granted a 30-day option to purchase an additional 2,124,000 shares.
Shares are expected to begin trading on the Nasdaq Global Select Market on May 1, 2026 under ticker SPTX, with the offering expected to close on May 4, 2026, subject to customary closing conditions.